Market revenue in 2023 | USD 56.4 million |
Market revenue in 2030 | USD 115.5 million |
Growth rate | 10.8% (CAGR from 2023 to 2030) |
Largest segment | Dual channel |
Fastest growing segment | Single Channel |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Single Channel, Dual Channel |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dual channel was the largest segment with a revenue share of 57.45% in 2023. Horizon Databook has segmented the Middle East & Africa deep brain stimulation devices market based on single channel, dual channel covering the revenue growth of each sub-segment from 2018 to 2030.
The MEA region includes South Africa, Saudi Arabia, UAE, and other countries. Increase in incidence of neurological diseases, such as Alzheimer's disease, dementia, and PD, is contributing to the market growth.
In May 2017, Global Plan of Action on Dementia developed by WHO has been adopted at World Health Assembly in Geneva to create awareness about dementia and increase funding for neology hospitals. Thus, government efforts coupled with developing healthcare infrastructure in the region is expected to further fuel growth of the market in the region.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account